Penlac Articles
Enrollment "well on track" for Ph III TLT trial
28 January 2008
Aventis nail fungus product OKed in USA
21 December 1999
Showing 1-2 of 2 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
